AusPAR: Eltrombopag olamine

Australian Public Assessment Report

AusPAR

AusPAR: Eltrombopag [PDF, 678.55 KB]

AusPAR: Eltrombopag [Word, 948.42 KB]

Attachment: Product Information: Eltrombopag olamine [PDF, 247.7 KB]

Attachment: Product Information: Eltrombopag olamine [Word, 103.64 KB]

Attachment: Extract from Clinical Evaluation Report: Eltrombopag olamine [PDF, 1.03 MB]

Attachment: Extract from Clinical Evaluation Report: Eltrombopag olamine [Word, 1.19 MB]

Device/Product Name

Revolade

Active ingredients

Eltrombopag olamine

AusPAR Date

3 December 2013

Published

8 January 2014

Submission Number

PM-2012-01934-3-2

Submission Type

Major variation (extension of indications)

Decision

Approved